复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中的安全性及疗效分析

doi:10.3969/j.issn.1000-8535.2024.03.015

摘要/Abstract

摘要： 目的探讨复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中的疗效。方法选择2019年6月—2023年1月在河南省许昌中医院诊治的79例缺血性脑卒中患者,按照入院就诊顺序采用奇偶法把患者分为联合组40例与传统组39例。传统组给予阿替普酶静脉溶栓治疗,联合组给予复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗,评价与记录联合组与传统组的疗效与安全性及治疗前、治疗14 d后Fugl-Meyer评定量表（FMA）与改良版Banhel评价指数（MBI）、血清β-内啡肽、前列腺素E2（PGE2）水平变化。结果治疗14 d后联合组的总有效率更高（97.5% vs 82.1%,P<0.05）,并发症发生率更低（5.0% vs 20.5%,P<0.05）。联合组与传统组治疗14 d后的FMA与MBI评分高于治疗前（P<0.05）,联合组治疗14 d后的FMA评分、MBI评分比传统组提高（P<0.05）。联合组与传统组治疗14 d后的血清β-内啡肽、PGE2水平低于治疗前（P<0.05）,联合组治疗14 d后的血清β-内啡肽、PGE2水平低于传统组（P<0.05）。结论复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中能提高效果,降低患者的肺部感染、尿路感染、静脉血栓、褥疮等并发症发生率,改善患者的运动与日常生活功能,还可降低患者血清β-内啡肽、PGE2水平。

关键词: 复方脑肽节苷脂注射液, 阿替普酶, 静脉溶栓, 急性缺血性脑卒中, β-内啡肽, 前列腺素E2

Abstract: Objective To explore and analysis the efficacy and safety of compound brain peptide ganglioside injection combined with alteplase intravenous thrombolysis in the treatment of acute ischemic stroke. Methods From June 2019 to January 2023,79 patients with ischemic stroke who were diagnosed and treated at Henan Xuchang Traditional Chinese Medicine Hospital were selected as the research subjects．According to the order of admission,the patients were divided into the combination group of 40 cases and the traditional group of 39 cases．The traditional group received intravenous thrombolytic therapy with alteplase,while the combination group received treatment with compound brain peptide ganglioside injection on the basis of the traditional group．The efficacy and safety and changes of the Fugl-Meyer rating Scale（FMA）and modified Banhel Evaluation Index（MBI）,serum β-endorphin,and PGE 2 levels in the combined and traditional groups were evaluated and recorded. Results After 14 days of treatment,the combined group had a higher overall response rate（97.5% vs 82.1%,P<0.05）and a lower complication rate（5.0% vs 20.5%,P<0.05）．FMA scores and MBI scores of the two groups after 14 days of treatment were higher than those before treatment（P<0.05）,and FMA scores and MBI scores of the combined group after 14 days of treatment were higher than those of the traditional group（P<0.05）．The contents of β-endorphin and prostaglandin E2 in two groups after 14 days of treatment were lower than those before treatment（P<0.05）,and the contents of β-endorphin and prostaglandin E2 in combination group after 14 days of treatment were lower than those in traditional group（P<0.05）. Conclusions The combination of compound brain peptide ganglioside injection and alteplase intravenous thrombolysis in the treatment of acute ischemic stroke can improve the treatment effect,reduce the incidence of complications such as pulmonary infections,urinary tract infections,venous thrombosis and bedsores in patients,improve patients' motor and daily life functions,and also reduce patients' serum levels of β-endorphins and prostaglandin E2．

Key words: compound brain peptide ganglioside injection, alteplase, intravenous thrombolysis, acute ischemic stroke, β- endorphins, prostaglandin E2

胡一凡. 复方脑肽节苷脂注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中的安全性及疗效分析[J]. 广州医药, 2024, 55(3): 306-310.

HU Yifan. Efficacy and safety analysis of compound brain peptide ganglioside injection combined with alteplase intravenous thrombolysis in the treatment of acute ischemic stroke[J]. Guangzhou Medical Journal, 2024, 55(3): 306-310.

参考文献

[1] 李佳,楚兰,王志,等.复方脑肽节苷脂注射液联合谷红注射液、吲哚布芬片治疗老年缺血性脑卒中的疗效[J].国际老年医学杂志,2023,44(3):284-288.
[2] HONG Q,YANG Y,WANG Z,et al.Longxuetongluo capsule alleviates lipopolysaccharide-induced neuroinflammation by regulating multiple signaling pathways in BV2 microglia cells[J].J Chin Med Assoc,2020,83(3):255-265.
[3] IYONAGA T,SHINOHARA K,MASTUURA T,et al.Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation[J].Hypertens Res,2020,43(2):99-110.
[4] 吕光辉,方侃,叶方.复方脑肽节苷脂注射液致顽固性呃逆1例[J].医药导报,2022,41(8):1232-1233.
[5] SHOOSHTARI M K,SARKAKI A,MANSOURI S M T,et al.Protective effects of Chrysin against memory impairment,cerebral hyperemia and oxidative stress after cerebral hypoperfusion and reperfusion in rats[J].Metab Brain Dis,2020,35(2):401-412.
[6] 马大伟,李伟,李春燕.复方脑肽节苷脂注射液联合替罗非班治疗急性脑梗死的临床研究[J].现代药物与临床,2022,37(7):1497-1501.
[7] YANG L X,CHEN F Y,YU H L,et al.Poncirin suppresses lipopolysaccharide(LPS)-induced microglial inflammation and ameliorates brain ischemic injury in experimental stroke in mice[J].Ann Transl Med,2020,8(21):1344.
[8] YUAN Y,MEN W,SHAN X,et al.Baicalein exerts neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway[J].Inflammopharmacology,2020,28(5):1327-1341.
[9] 翟明明,邹俊杰,李昭盈.复方脑肽节苷脂联合依达拉奉治疗急性脑梗死的疗效及其对血清S100β、NSE、8-iso-PGF2α和MDA水平的影响[J].药物评价研究,2021,44(5):1060-1065.
[10] LI Y,WANG J,CHEN S,et al.MiR-137 boosts the neuroprotective effect of endothelial progenitor cell-derived exosomes in oxyhemoglobin-treated SH-SY5Y cells partially via COX2/PGE2 pathway[J].Stem Cell Res Ther,2020,11(1):330.
[11] PERROT C Y,HERRERA J L,FOURNIER-GOSS A E,et al.Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin,connexin-43,and R-Ras[J].Sci Rep,2020,10(1):11186.
[12] 李兴明,刘娟娟,陈俊斌,等.复方脑肽节苷脂注射液对急性脑梗死的临床疗效及对患者Lp-PLA2 hs-CRP NSE水平的影响[J].河北医学,2020,26(3):393-397.